Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Post-approval studies (Phase 4)Study completedNCT01536535
What this trial is testing

Predicting Response to Standardized Pediatric Colitis Therapy

Who this might be right for
Ulcerative Colitis
Connecticut Children's Medical Center 431
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151326
What this trial is testing

Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 60
Testing effectiveness (Phase 2)Study completedNCT04665843
What this trial is testing

Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Hoffmann-La Roche 123
Testing effectiveness (Phase 2)Looking for participantsNCT07061535
What this trial is testing

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Extensive Stage Lung Small Cell CancerExtensive-Stage Small-Cell Lung Cancer+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Large-scale testing (Phase 3)Looking for participantsNCT07300514
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Who this might be right for
Maintenance Treatment of Peripheral T-cell Lymphoma
Fudan University 136
Large-scale testing (Phase 3)UnknownNCT03942094
What this trial is testing

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseNilotinib
Shenzhen Second People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT00468039
What this trial is testing

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 94
Large-scale testing (Phase 3)Active Not RecruitingNCT04934475
What this trial is testing

MInimal Residual Disease Adapted Strategy

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 791
Not applicableStudy completedNCT03154151
What this trial is testing

Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors

Who this might be right for
Post-Traumatic Stress Disorder
Icahn School of Medicine at Mount Sinai 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07537777
What this trial is testing

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)First-line Targeted Therapy FailureOligometastatic Hepatocellular Carcinoma+3 more
Nanfang Hospital, Southern Medical University 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07633873
What this trial is testing

SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）

Who this might be right for
Non-Small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 500
Not applicableUnknownNCT05396495
What this trial is testing

Safety and Feasibility of the NeurolyserXR for Sacroiliac Joint Pain

Who this might be right for
Sacroiliitis
FUSMobile Inc. 10
Not applicableLooking for participantsNCT06767631
What this trial is testing

Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus

Who this might be right for
StrokeSpasticityEquinovarus Foot
Universitaire Ziekenhuizen KU Leuven 12
Not applicableStudy completedNCT02789137
What this trial is testing

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 111
Large-scale testing (Phase 3)Study completedNCT00740883
What this trial is testing

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Who this might be right for
Pulmonary Embolism
University Hospital, Brest 374
Large-scale testing (Phase 3)Study completedNCT03358472
What this trial is testing

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

Who this might be right for
Head and Neck Cancer
Incyte Corporation 89
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableLooking for participantsNCT05878977
What this trial is testing

Biomarkers in Immunotherapy of Melanoma

Who this might be right for
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more
Institute of Oncology Ljubljana 150
Next Page